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Abstract 
Background 
The toxicological properties of manufactured nanomaterials (MNMs) can be different from 
their bulk-material and uncertainty remains about the adverse health effects they may have on 
humans. Proposals for OELs have been put forward which can be useful for risk management 
and workers’ protection.  We performed a systematic review of proposals for OELs for 
MNMs to better understand the extent of such proposals, as well as their derivation methods. 
Methods 
We searched PubMed and Embase with an extensive search string and also assessed the 
references in the included studies. Two authors extracted data independently. 
Results 
We identified 20 studies that proposed in total 56 OEL values. Of these, two proposed a 
generic level for all MNMs, 14 proposed a generic OEL for a category of MNMs and 40 
proposed an OEL for a specific nanomaterial. For specific fibres, four studies proposed a 
similar value but for carbon nanotubes (CNTs) the values differed with a factor ranging from 
30 to 50 and for metals with a factor from 100 to 300. The studies did not provide 
explanations for this variation. We found that exposure to MNMs measured at selected 
workplaces may exceed even the highest proposed OEL. This indicates that the application 
and use of OELs may be useful for exposure reduction. 
Conclusion 
OELs can provide a valuable reference point for exposure reduction measures in workplaces. 
There is a need for more and better supported OELs based on a more systematic approach to 
OEL derivation. 
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BACKGROUND 
Nanotechnology is an expanding field, with new manufactured nanomaterials (MNMs) and 
products containing these materials appearing on the market every year. There is also a 
growing diversity of industries in which MNMs are used such as construction, health care, 
energy, automobile and aerospace, chemical products, electronics and communication, 
cleaning and maintenance, textile, and military. This means that a growing number of 
workers worldwide is potentially exposed to MNMs (Kaluza S et al., 2009). Systematic 
reviews of exposure studies confirm that workplace exposure to nanoparticles occurs and that 
control measures can be improved to reduce exposure (Debia, 2016, Ding et al., 2016). 
Nanoparticles can be classified into three categories. There are naturally occurring 
nanoparticles resulting from the nucleation of low-volatile gas-phase compounds followed by 
growth into small particles such as via volcanic eruptions and forest fires, via erosion. Then, 
there are also incidental nanoparticles generated (as by-products) of heating and combustion 
processes, machining and other high-energy processes, also called process-generated 
nanoparticles or combustion-derived nanoparticles (Donaldson et al., 2005). Finally there are 
man-made manufactured nanoparticles intentionally produced by industry, as defined by the 
European Commission (E C 2011), such as carbon nanotubes. Since different sources of 
nanoparticles require different approaches, in this article we focus only on the third category, 
i.e. MNMs in the workplace. 
Many MNMs are still given the name of their bigger chemical bulk material, but due to their 
extremely small size (≤100 nm), their physical and chemical properties can be different from 
those of the ‘mother’ material of the same structure and composition (Kulinowski K and B., 
2011). The International Organization for Standardization (ISO) defined bulk material as “a 
material of the same chemical composition as nano-objects and their agglomerates and 
aggregates (NOAAs), at a scale greater than the nanoscale.” 
The toxicity of MNMs largely depends on numerous physicochemical properties, including 
size, shape, composition, surface characteristics, charge and solubility. While workers may be 
exposed to MNMs via inhalation, ingestion or dermal absorption, the inhalation pathway is 
the most likely to result in larger systemic doses (Oberdorster et al., 2005). Once inhaled, the 
mechanisms, pattern and efficiency of particle deposition in the respiratory tract remains a 
function of its aerodynamic diameter, shape and density. Particles with a diameter from 1 to 
100 nm show a much higher fraction of deposition in the pulmonary region of the lung 
compared to larger particles. Of inhaled particles with various diameters, only those in the 
nanorange are known to systematically translocate from the lungs into the circulatory system 
through the air-blood tissue barrier and subsequently accumulate in secondary organs and 
tissues of the body (Geiser and Kreyling, 2010). Due to inherent ethical concerns, most 
evidence comes from rodent studies, with the most reliable data using quantitative particle 
biokinetics assessments, which balance the total nanoparticle fractions as measured in the 
rodent body and total excretion collected between application and autopsy (Geiser and 
Kreyling, 2010). In a study by Semmler-Behnke et al with nanosized 192Iridium, it was 
confirmed that nanoparticles are predominantly retained long-term within interstitial spaces 
of the alveolar region of the rat lung, with limited translocation toward the circulation 
(Semmler-Behnke et al., 2007). A series of studies of particle inhalation in rodents has shown 
that nanoparticle translocation into the circulation and to secondary organs remains highly 
dependent on the nanoparticle physicochemical properties, including size, material, surface 
charge and surface modifications (Kreyling et al., 2002, Semmler et al., 2004, Kreyling et al., 
2009). There is currently no evidence of the nanoparticle translocation to the circulation and 
to secondary organs beyond 1% of the mass-based dose (Mills et al., 2006, Wiebert et al., 
2006, Kreyling et al., 2014). However, this figure is based on extrapolation from animal 
studies, resulting in the lack of precise information for inhaled MNM bio kinetics and long-
term results in the human model. Nevertheless, while acute effects from MNM translocation 
to secondary organs are not likely to be considerable, it is possible that chronically exposed 
populations may face greater risks from cumulative, low-dose translocation processes, for 
example from biopersistent MNMs. 
Occupational Exposure Limits (OEL) for chemical substances have long been in use for 
controlling workplace exposures. In 1887, Germany was the first country to publish selected 
limit values that were considered occupational exposure limits, but it was only in 1977 that 
the term had been fully adopted by the International Labour Organization (ILO) and later, in 
1981, that the World Health Organization (WHO) started to use the same term: occupational 
exposure limits (Schulte et al., 2010). 
ISO defines OELs as a “maximum concentration of airborne contaminants deemed to be 
acceptable, as defined by the authority having jurisdiction” (ISO 16972:2010). 
Even though there is no generally accepted uniform definition for an OEL, there is at least 
agreement that they constitute a level of usually airborne exposure to an agent beyond which 
unacceptable health risks might occur. In this general sense, we will also use the term OEL in 
this article. OELs are commonly established based on the actual state of the scientific 
knowledge and intended for protecting against adverse health effects for workers Health-
based OELs are usually based on the estimation of a no effect level and therefore they 
represent an exposure level below which no adverse health effects are expected(Stouten et 
al., 2008).  However, for genotoxic and carcinogenic substances, that have no threshold 
below which there is no detectable effect, some countries, for example the Netherlands and 
Germany, have developed what they call risk-based OELs  (S E R 2007, B A u A 2013, Ding 
et al., 2014). These risk concepts define a tolerable risk level and an acceptable risk level. 
Germany defines a tolerable risk level with a calculated additional cancer risk of 4:1 000, 
meaning that statistically 4 out of 1 000 persons exposed to the substance during their 
working life may develop cancer, and they define an acceptable risk level with a calculated 
cancer risk level of 4:10 000 (until 2013) and 4:100 000 (at the latest in 2018). In the 
Netherlands, the levels are respectively 4:1 000 and 1:1 000 000 (new cancers per year). This 
means that these countries acknowledge that no safe level can be defined, that even the 
lowest exposures may induce an adverse effect and accept that a certain number of workers 
may develop cancer each year as a result of the exposure. On the other hand,  countries also 
derive OELs that include technical and economic feasibility considerations for regulatory 
purposes and these are thus not entirely health or risk based and these are sometimes called 
administrative OELs. The naming of OELs is quite inconsistent between different national 
and international bodies. 
Within the REACH framework the EU defines derived no-effect levels (DNEL) for 
substances with a detectable threshold for health-based effects (European Chemical Agency, 
2012). For genotoxic carcinogenic substances, without a threshold effect, the EU defines 
derived minimal effect levels (DMEL), which is a semi-quantitative value. In the US, the 
American Conferences of Governmental Industrial Hygienists (ACGIH) defines threshold 
limit values (TLV) for health-based OELs. In their local context, these values may have a 
distinct and complementary meaning. The values may have been established based on what 
was considered to be technically feasible, or may have been calculated with the goal of 
preventing adverse health effects, or for limiting the potential number of health effects. 
These factors make it complex to compare the values, although efforts have been made to 
harmonize procedures for deriving OELs (Deveau et al., 2015). 
Regardless of the difficulty of unambiguously defining OELs, they form an important tool for 
occupational risk management within a health context. They provide a rationale for risk 
assessment and control measures. Based on long-term analysis of exposures at the workplace, 
Creely et al. argued that regulation, including the establishment of OELs, has led to a 
decrease in workplace exposure to a number of hazardous chemicals (Creely et al., 2007). 
Moreover, according to common principles in behavioural theory, formulating a goal that has 
to be achieved is a strong driver for desirable behaviour (Locke and Latham, 2002). 
Practice shows that OELs for chemical substances in general must be regarded as being 
provisional, requiring regular updating to comply with growing knowledge of the hazards. 
Therefore, insufficient scientific evidence should not be a barrier to accept provisional OELs 
but in contrary asks for the operationalization of the existing knowledge and if necessary for 
the application of precautionary measures. In fact, international experts advocate the 
development of provisional OELs for MNMs (van Broekhuizen and Dorbeck-Jung, 2013, 
Gordon et al., 2014). 
Currently, specific regulatory OELs for MNMs have not been established by the EU or by 
any national authority and it is expected that it may take a long time before OELs have been 
derived for all highly diverse frequently used MNMs. This is mainly due to the still existing 
large gaps in knowledge on particle toxicology, the high diversity of the newly developed, 
and used, MNMs, the uncertainties about their hazardous nature and the on-going discussions 
on the metrics to be used for the nano-OELs, be it mass-based or particle number based. 
Alternatively, generic precautionary particle number based nano reference values (NVR) for 
groups of nanomaterials have been proposed in some countries (I F A 2009, S E R 2012). 
 
Here the adjective ‘reference’ is used to emphasize that these values are not health-based and 
indicates that these values should be for risk management: as an incentive to take control 
measures if the NVR is exceeded (S E R 2012, van Broekhuizen and Dorbeck-Jung, 2013). 
For a few specific nanomaterials the industry and research have advised an OEL or a DNEL. 
NIOSH (2011) proposed an OEL for nano-TiO2 based on toxicological data and used the US 
threshold limit value (TLV) for coarse TiO2 (of 1.5mg/m
3
) as a reference. Bayer (Pauluhn,
2010), Nanocyl (Luizi, 2009) and NIOSH (National Institute for Occupational Safety and 
Health, 2013) proposed OELs for multiwall carbon nanotubes (MWCNTs). DNELs were 
calculated in an experimental study by Stone et al applying the DNEL methodology with the 
prescribed assessment factors to MWCNTs, fullerenes, silver (Ag) and titanium dioxide 
(TiO2) (Stone, 2009). 
Currently, the World Health Organization is preparing a guideline for protecting workers 
from potential risks of MNMs. One of the questions is: which OEL/reference value should 
specific nanomaterials or groups of materials be assigned to? So far, there has been limited 
information on the development and use of OELs for MNMs (Schulte et al., 2010, Gordon et 
al., 2014). To address this problem, we conducted a systematic review of existing OELs for 
MNMs and analysed how these values were derived. 
OBJECTIVE 
To develop an exhaustive list of OELs that have been proposed for MNMs, and to describe 
differences and similarities in the approaches by which they were derived. 
METHODS 
Inclusion criteria 
We based our inclusion criteria on the PICO approach, which is an acronym that specifies 
that eligible studies must comply with criteria for one or more of the following elements: 
participants (P), intervention/exposure (I/E), control (C), outcome (O), and study design (S) 
(Guyatt et al., 2011, Morgan et al., 2016). These criteria were defined as follows. 
Study design: We included all proposals using an exposure limit approach or that proposed a 
quantitative exposure limit value for an MNM or a group of MNMs for protecting workers 
exposed to manufactured nanomaterials from adverse health effects. To be included, the 
studies also had to indicate the process by which the authors derived the OELs. 
Participants: the OEL is a tool intended to protect workers potentially exposed to MNMs. 
Intervention/Exposure: the OEL should be formulated as a concrete exposure value for a 
MNM or group of MNMs and should address the MNMs’ potential for adverse health effects 
and it should indicate how the exposure should be measured and expressed. 
We considered that the control (C) and outcome (O) elements were not applicable in our 
specific situation where we are not looking for effects of controlled studies but where we 
want to list a specific set of OEL proposals 
Search methods for inclusion of studies 
Electronic searches 
We conducted a systematic literature search in PubMed and Embase until 15 February 2016, 
which was not limited to the English language. The search string contained specific search 
words for MNMs, such as nanomaterial and synonyms, occupational exposure limit and 
synonyms, and OELs. We combined both search strings with AND. (See Appendix 1 for the 
full search strategy) 
Searching other sources 
We checked the reference lists of all included studies to find additional proposals. We also 
asked experts involved in the development of the WHO Guidelines on protecting workers 
from potential risks of manufactured nanomaterials (draft, WHO 2016) or one of the 
systematic reviews of the WHO guideline to report any proposed OELs for MNMs that they 
knew of. 
Analysis 
We grouped the OELs per MNM or group of MNMs and analysed per OEL which process 
was used to derive the OEL value. Next, we categorised the derivation processes according to 
Gordon 2014 (Gordon et al., 2014), which we slightly adapted as: 
- Traditional quantitative risk assessment (QRA) defined as a stepped approach that 
starts with assessing toxicological data for substance and selecting a dose – usually a 
no-observed-adverse-effect-level or benchmark dose to use as a point of departure to 
calculate a human equivalent concentration and by applying various uncertainty and 
modifying factors finally arriving at an OEL. 
- Bridging or read across defined as applying hazard information of one material (nano- 
or bulk material) to predict the hazards of another material (Patlewicz et al., 2013); 
Oomen, 2015 #10}. Even though the methods has been advocated for bulk materials 
to save time, money and animals, there is no consensus on how to do this (Patlewicz 
et al., 2013). 
- Using environmental exposure limits for particulate matter (World Health 
Organisation, 2005) 
- Grouping defined as an approach that groups MNMs based on a common aspect of 
the material (Oomen et al., 2015). Even though grouping should be based on similar 
principles as read-across, we believe that it is important to distinguish grouping from 
read-across for one material because of its practical consequences. 
Data collection 
Two authors (RM, JV) independently extracted the following data per proposal into an Excel 
sheet: MNM, value(s), measurement metric(s), approach (how were the OELs derived), year 
of development, country, category of development, key study. 
Risk of bias assessment 
We did not try to assess the risk of bias in the development process since there are no 
generally accepted methods to derive OELs. 
RESULTS 
Results of the searches 
Our systematic searches resulted in 498 references. The search in MEDLINE/PubMed 
resulted in 259 references and the search in Embase in 239, altogether 498 references. In 
addition, we located 23 potential references from other sources. After removing the 
duplicates this resulted in 397 references that we screened for inclusion based on title and 
abstract. This resulted in 73 references that we checked for inclusion based on full text 
assessment. After the exclusion of those (n = 49) that did not meet our inclusion criteria, we 
included 24 articles. To prevent double counting of studies, we aggregated articles that 
described the same values into one study. For example, we aggregated van Broekhuizen 
2011, 2012, 2013 and the German Institute of Occupational Safety and Health (IFA) 2016 
into one study van Broekhuizen 2012 because IFA 2016 explicitly referred to van 
Broekhuizen as the source of their values  (van Broekhuizen and Reijnders, 2011, van 
Broekhuizen et al., 2012, van Broekhuizen and Dorbeck-Jung, 2013, Institut für 
Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung, 2016). This finally resulted in 
 
the inclusion of 20 studies. Some groups updated their proposals for OELs over time. In this 
case, we only included the most recent reported value. Many studies included more than one 
proposal and this resulted in 56 proposals for OELs. See the flow diagram (Figure 1). We 
have attached also a comprehensive list with all the full text articles that have been screened 
and included (Appendix 2). 
Description of included studies 
See Table 1 for a description of included studies. 
Nanomaterials addressed 
Studies with a general approach 
We found two studies that took a generic approach and proposed an OEL for all MNMs. In 
one study, the OEL was based on environmental exposure limits for particulate matter (PMx) 
(Guidotti, 2010). In the other study, the OEL was based on the number of times the potential 
MNM exposure concentration exceeded the local background level (McGarry et al., 2013). 
Studies with a categorical approach 
We found six studies that used a categorical approach when they derived an OEL for a group 
of nanomaterials (British Standards Institution, 2007, Pauluhn, 2011, Kuempel et al., 2012, 
van Broekhuizen et al., 2012, German Hazardous Substances Committee, 2013, Stockmann-
Juvala et al., 2014). Groups were: fibres, granular biopersistent particles (GBP), MNMs with 
bulk material classified as CMAR-chemicals (carcinogenic, mutagenic, asthmagenic, 
reproductive risk), MNMs that are soluble, and MNMs that are non-biopersistent. 
Studies with a MNM specific approach 
Most studies evaluated specific MNMs. There were seven that evaluated TiO2 (Kuempel et 
al., 2006, Aschberger et al., 2011, National Institute for Occupational Safety and Health, 
2011, Ogura et al., 2011, Warheit, 2013, Stockmann-Juvala et al., 2014, Świdwińska-
Gajewska and Czerczak, 2014), six that evaluated carbon nanotubes (Luizi, 2009, Stone, 
2009, Pauluhn, 2010, Aschberger et al., 2011, National Institute for Occupational Safety and 
 
Health, 2013, Nakanishi et al., 2015), three evaluated fullerene (Stone, 2009, Aschberger et 
al., 2010, Shinohara et al., 2011), three evaluated nanosilver (Stone, 2009, Aschberger et al., 
2011, Swidwinska-Gajewska and Czerczak, 2015), and one study evaluated  amorphous 
SiO2, low-toxicity dust, nanocellulose and nanoclays (Stockmann-Juvala et al., 2014). 
Routes of exposure 
All proposals addressed chronic inhalation exposure of the workers. One study also evaluated 
dermal and oral exposure to carbon nanotubes and fullerene (Stone, 2009). Stone 2009 and 
Aschberger 2010 also derived OEL values for short-term (15 minutes) inhalation exposure of 
the workers (Stone, 2009, Aschberger et al., 2010). 
There were 15 studies which used traditional quantitative risk assessment (QRA) (Kuempel et 
al., 2006, Luizi, 2009, Stone, 2009, Aschberger et al., 2010, Pauluhn, 2010, Aschberger et 
al., 2011, National Institute for Occupational Safety and Health, 2011, Ogura et al., 2011, 
Shinohara et al., 2011, National Institute for Occupational Safety and Health, 2013, Warheit, 
2013, Stockmann-Juvala et al., 2014, Świdwińska-Gajewska and Czerczak, 2014, Nakanishi 
et al., 2015, Swidwinska-Gajewska and Czerczak, 2015). There were all together six studies 
that used bridging or read across from short-term in vivo studies as follows. Three studies 
adjusted OELs that exist for the larger counterpart bulk material (British Standards 
Institution, 2007, van Broekhuizen et al., 2012, Institut für Arbeitsschutz der Deutschen 
Gesetzlichen Unfallversicherung, 2016); four studies used a bridging and a grouping 
approach (British Standards Institution, 2007, van Broekhuizen et al., 2012, German 
Hazardous Substances Committee, 2013, Stockmann-Juvala et al., 2014); three studies used 
only a bridging approach (British Standards Institution, 2007, van Broekhuizen et al., 2012, 
Stockmann-Juvala et al., 2014); two used only a grouping approach (van Broekhuizen et al., 
2012, German Hazardous Substances Committee, 2013). Then there were two studies that 
used environmental exposure limits for particulate matter (Guidotti, 2010, McGarry et al., 
2013), and one study that used both a categorical QRA and a grouping approach based on 
common aspects of MNMs (Pauluhn, 2011). 
None of the studies was based on read across from in-vitro studies. 
Geographical location and research groups 
The included proposals were performed by a limited number of research groups. There were 
three studies funded by the EU: the ENHRES programme (Engineered Nanoparticles: 
Review of Health and Environmental Safety) (Stone, 2009, Aschberger et al., 2011) and the 
Scaffold programme (Stockmann-Juvala et al., 2014). There were ten studies conducted by 
national occupational health or technological research institutes. One study from the United 
Kingdom by the British Standards Institution (British Standards Institution, 2007), three 
studies from NIOSH in the United States (Kuempel et al., 2006, National Institute for 
Occupational Safety and Health, 2011, National Institute for Occupational Safety and Health, 
2013), one from BAuA in Germany (German Hazardous Substances Committee, 2013), three 
from NEDO in Japan (Ogura et al., 2011, Shinohara et al., 2011, Nakanishi et al., 2015), and 
two from Poland (Świdwińska-Gajewska and Czerczak, 2014, Swidwinska-Gajewska and 
Czerczak, 2015). There were two studies from universities, one from the Netherlands (van 
Broekhuizen et al., 2012) and the second one from Australia (McGarry et al., 2013). There 
were four studies by the chemical companies: Bayer (Pauluhn, 2010, Pauluhn, 2011), 
BASF/Nanocyl (Luizi, 2009), and DuPont (Warheit, 2013). There was also one proposal by 
an individual editor of a journal in Canada (Guidotti, 2010). 
Terminology used 
Five research groups used the term occupational exposure limit (OEL) (Pauluhn, 2010, 
German Hazardous Substances Committee, 2013, Warheit, 2013, Stockmann-Juvala et al., 
2014, Nakanishi et al., 2015). For one group this term had a regulatory meaning (German 
Hazardous Substances Committee, 2013) but not for the rest (Pauluhn, 2010, Warheit, 2013, 
Stockmann-Juvala et al., 2014, Nakanishi et al., 2015). 
The four proposals by the Japanese research groups also used the term OEL but with a suffix 
indicating subchronic exposure spanning over 15 years called OEL period-limited or OEL PL 
(Ogura et al., 2011, Shinohara et al., 2011, Nakanishi et al., 2015). 
There were two related groups which used the same data from the ENRHES 2009 project, but 
used different terms for the OELs. Both Stone et al. and Aschberger et al. applied the 
methodology as described in the appendix of the European Chemical Agency, REACH 
project, for deriving DNELs (European Chemical Agency, 2012, Tynkkynen et al., 2015), 
Aschberger and colleagues used an indicative no effect level (INEL), while Stone et al. used 
a derived no effect level (DNEL) (Stone, 2009, Aschberger et al., 2010, Aschberger et al., 
2011). The reason for this was that the authors want to highlight that the derived INEL values 
should not be considered as having the same regulatory status as the DNEL values. 
Van Broekhuizen proposed a nano reference value (NRV) with a provisional status, not a 
regulatory one (van Broekhuizen et al., 2012). 
Two studies by NIOSH used a recommended exposure limit (REL) which is a term used by 
NIOSH to describe an OEL, as the Occupational Health and Safety Administration (OSHA) 
uses permissible exposure limits (PELs) which are mandatory according to regulation 
(National Institute for Occupational Safety and Health, 2011, National Institute for 
Occupational Safety and Health, 2013). 
The British Standards Institution (BSI) used the term benchmark exposure level (BEL), 
which indicates fairly well that this is not a health-based recommendation but a tool to help in 
assessing the need for control measures (British Standards Institution, 2007). 
One study used a no effect concentration in air, which is an unusual term that was directly 
based on the findings of an animal exposure study carried out by the same research group 
(Luizi, 2009). 
One study used particle control values (PCVs), which they defined as a concentration that 
exceeds three times the local back ground particle concentration in the air. For this 
concentration value, emission or exposure controls may need to be implemented or modified, 
or further assessment of the controls be undertaken (McGarry et al., 2013). 
Two Polish studies used a maximum admissible concentration-time weighted average 
(MAC-TWA) (Świdwińska-Gajewska and Czerczak, 2014, Swidwinska-Gajewska and 
Czerczak, 2015), which is defined as the time-weighted average concentration for a 
conventional 8-hour workday and a work week, to which workers may be exposed during 
their whole working life, without any adverse effects on their health. 
One study used benchmark occupational exposure level (Guidotti, 2010). This proposal was 
derived using an environmental approach, and the author suggested this term so that it should 
not be confused with an OEL. 
Kuempel at al. used a benchmark dose approach and determined and extrapolated the values 
belonging to the lower limit of the 95% confidence interval of the dose that caused a 0.1 % 
excess risk of lung cancer in rats (BMDL) (Kuempel et al., 2006). They did not use the term 
OEL and discussed the derived OEL only as a human equivalent exposure estimate. 
Exposure metrics used 
The majority of OELs are only expressed as mass concentration (µg/m
3
). There are, however,
some exceptions. There is one proposal expressed in particle concentration (either fibers/cm
3
or particle/ml) for each of the following: MNM (McGarry et al., 2013), fibers (British 
Standards Institution, 2007, van Broekhuizen et al., 2012, Stockmann-Juvala et al., 2014), 
GBP for metals and metal oxides (van Broekhuizen et al., 2012), and nanocellulose 
(Stockmann-Juvala et al., 2014). And there are two proposals expressed in particle- and mass 
concentrations for GBP insoluble nanomaterials (British Standards Institution, 2007). 
Four out of 56 OEL-proposals contain a value both for mass and particle number 
concentration (British Standards Institution, 2007, German Hazardous Substances 
Committee, 2013).  Only one study had proposals for mass-, particle- and surface 
concentration (nm
2
/cm
3
) for nanosilver (Stone, 2009).
For readability and clarity, we transformed all inhalation mass concentration values that were 
expressed as mg/m
3
 into µg/m
3
.
Proposed OELs reported in studies 
See Table 2 for OEL values reported in the included studies. 
OELs with a general approach 
McGarry proposes a particle concentration of three times the local back-ground particle 
concentration (LBPC) level that indicates particle emission from the process at hand. This 
would also take into account ‘natural’ variation of the background level. The authors propose 
that control measures may need to be implemented if this level is exceeded for more than a 
total of 30 minutes during a workday, and/or if a single short-term measurement exceeds five 
times the LBPC. Guidotti proposes as the benchmark occupational exposure level value to 
simply use the value of 30 µg/m
3 
that is set for particulate matter (PMx) in ambient air and as
agreed upon for the general population in Canada (Guidotti, 2010). He argued that there are 
many similarities between PMx and MNMs and that if these values are deemed fit to protect 
the general population, this probably also protects workers. 
OELs for fibres 
For fibres, all four included proposals used the same value, a level ten times lower than the 
asbestos OEL of 0.1 fibres/ml, because of the use of a safety margin of a factor 10. This 
particular value was chosen because of the assumed physico-chemical similarities with 
asbestos (British Standards Institution, 2007, van Broekhuizen et al., 2012, German 
Hazardous Substances Committee, 2013, Stockmann-Juvala et al., 2014). Moreover, 
Stockmann-Juvala mentioned that this limit is "based on the precautionary 
principle"(Stockmann-Juvala et al., 2014). Similarly based on what is tolerated for asbestos 
exposure, the German authority considers a level that is ten times lower an acceptable level 
(Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, 2008, German Hazardous Substances 
Committee, 2013). 
OELs for Granular Biopersistent Nanoparticles (GBP) 
For GBPs, van Broekhuizen proposes two groups based on the classification recommended 
by the German Institute of Occupational Safety and Health (IFA): one category with a density 
higher than 6000 kg/m
3
 and the second one having a lower density than this value (van
Broekhuizen et al., 2012). The starting point for the number-based reference values is the 
calculation of the number of nanoparticles with a diameter of 100 nm that constitute a mass 
of 0.1 mg/m
3
. Values are defined as corrected for the background concentrations.
OELs for non-biopersistent nanoparticles 
Van Broekhuizen proposes the same OEL as for the bulk material in the case that the 
chemical is soluble or not biopersistent (van Broekhuizen et al., 2012). 
OELs for specific MNMs 
Carbonaceous material 
For carbon nanotubes and nanofibers, the proposed OELs differ considerably. The lowest 
proposed value is 0.67 µg/m
3
 (Stone, 2009), which is smaller than 1 µg/m
3
 recommended by
NIOSH 2013 (National Institute for Occupational Safety and Health, 2013). Nakanishi 
proposes a value that is at least 30 times larger but that would protect only for 15 years 
(Nakanishi et al., 2015), while the NIOSH value is calculated based on 45-year working 
lifetime. 
Also for fullerenes, the values differ by a factor of 50 with the same difference that the 
highest value protects only for15 years (Shinohara et al., 2011). The value proposed by 
Aschberger at al. 2011 is significantly lower (Aschberger et al., 2011). 
With 120 and 240 µg/m
3
, the OEL values for carbon black (Kuempel et al., 2006) are much
higher than for carbon nanotubes for which the highest value is 50 µg/m
3
 (Pauluhn, 2010).
Metals and metaloxides 
As for nanosilver, the differences are considerable with 0.098 µg/m
3
 based on a large
extrapolation factor and effects on the lungs, and 0.67 µg/m
3
 based on more systemic effects
(Stone, 2009, Aschberger et al., 2010, Aschberger et al., 2011). However, the Polish group 
proposed 100 to 15 times higher value of 10 µg/m
3
 which was already considerably lower
than the current value of 50 µg/m
3 
(Swidwinska-Gajewska and Czerczak, 2015). The authors
provide no clear justification for such high values. 
Also for titanium dioxide there is considerable variation. Aschberger 2010 proposed 17 
µg/m
3
, which is the lowest compared to the other groups. The highest limit was proposed by
Warheit 2013 with 5000 µg/m
3
 which is almost 300-fold higher (Warheit, 2013). Three
studies proposed the same value of 300 µg/m
3
 (National Institute for Occupational Safety and
Health, 2011, Stockmann-Juvala et al., 2014, Świdwińska-Gajewska and Czerczak, 2014) 
where we assumed that two of those values were simply taken over from NIOSH, but this 
was not clearly stated in the papers. 
For acute exposure to nanocarbon, only Aschberger and Stone derived values. For inhalation 
of fullerenes C60 the limits were identical, 44.4 µg/m
3 
(Stone, 2009, Aschberger et al., 2011).
For acute dermal exposure Stone set two limits: 0.414 mg/person bodyweight and 1.241 
mg/person bodyweight based on different assumptions in the derivation (Stone, 2009). 
Other materials 
For other MNMs there are only single values available that are not proposed by other groups 
such as for low-toxicity dust, nanoclays, nanocellulose (Stockmann-Juvala et al., 2014), 
CMAR and soluble nanomaterials (British Standards Institution, 2007), and non-biopersistent 
nanomaterials (van Broekhuizen et al., 2012). 
DISCUSSION 
In total, we found 56 proposals for OELs for MNMs in 20 papers. Of these two proposed a 
level for all MNMs, 14 proposed OELs for a category of MNMs and 40 proposed OELs for a 
specific material. For fibres, four studies proposed a similar value but for CNTs the values 
differed with a factor of 30 to 50 and for metals with a factor of 100 to 300. We could not 
explain these differences. 
When we compare the exposure levels that have been reported in workplace exposure studies 
to the OEL values that we have reported here, it seems that there is ample room for a 
reduction of exposure in workplaces to comply with the proposed OELs. Debia et al. reported 
occupational exposure to carbon nanofibers (CNFs) in potential exposure situations with 
values ranging from not detected to 193 fibres/cm
3
 for studies that measured particle number
concentrations and from not detected  to 1 000 µg/m
3 
for studies that measured mass
concentration (Debia, 2016). Most of these values exceed the proposed OELs discussed in 
this paper. For CNTs, there were only two exposure situations that exceeded the highest 
proposed OEL of 50 µg/m
3
 but the lowest OEL of 0.67 µg/m
3
 was exceeded in almost all
situations that reported mass concentrations. For TiO2 on the other hand, all but one exposure 
situation was below the NIOSH recommended value of 300 µg/m
3
. For nanosilver, only two
out of ten exposure situations were below the proposed OEL of 0.33 µg/m
3
 based on
inhalation exposure. Because these were workplaces that admitted researchers to take 
 
measurements, it is conceivable that in many other workplaces exposures will be higher. 
Applying and using the OELs presented here will be a helpful indication that control 
measures should be taken. 
The strength of our study is that we performed a systematic search to identify developed 
OELs, assessed them, and listed them in a systematic way. We did not exclude studies based 
on language or on publication status. We believe that we have compiled a comprehensive list 
of all available values. The proposed values can be used as reference or benchmark values for 
comparison with workplace measurement and for risk management. 
One of the limitations of our review is that we could not compare in detail the different 
methodologies used to derive the OELs. However, for those that used quantitative risk 
assessment, differences in the proposed levels can be explained by the animal studies used, 
how no-observed-adverse-effect level (NOAEL) were identified in the studies and which 
adjustment factors were used to extrapolate the results to a human exposure during an entire 
working life. Another limitation is that the studies did not always report sufficient 
information on the type of MNM studied. For example, TiO2 may have different crystal 
structures with different toxicological properties. From the studies it was not always clear 
which form of TiO2 was considered. 
Some studies indicated that the values were meant as a time-weighted average (TWA) over 
an eight-hour working day and a 40-hour workweek. Some advised as well how to calculate a 
value for a TWA-15 minute for short-term exposure, also referred to as STEL (Short Term 
Exposure Limit). By definition all OELs are 8 hour-TWA, unless otherwise stated. There is a 
similar situation with the interpretation of the OELs where some authors mentioned that the 
proposed values should prevent adverse effects over the time span of a 45-year working life 
but others only proposed this for a period of 15 years. Another limitation is that OELs assume 
 
that the MNMs are measured as primary nanoparticles. However, workplace exposure studies 
indicate that most MNMs are present in microsized agglomerates, which may also be the case 
for the rodent studies (Debia, 2016). It is unclear how this would be taken into account. 
Progress in the nanotechnology field is continuously growing. In his 2006 article, Maynard 
presented five challenges regarding nanotechnology research that would span over the 
following two decades. Among the challenges the author proposed for the next decade the 
development of “instruments to assess exposure to manufactured nanomaterials” including at 
the workplace (Maynard et al., 2006). Our review is timely in this fashion, but still more 
research is needed regarding OELs. 
Implications for practice 
The OELs listed here can be used as reference or benchmark values for comparison with 
workplace exposure towards a better understanding of the need for control measures. For 
some MNM categories such as fibres, one concrete OEL was proposed by four different 
studies (British Standards Institution, 2007, van Broekhuizen et al., 2012, German Hazardous 
Substances Committee, 2013, Stockmann-Juvala et al., 2014). For other categories or specific 
MNMs there is a range of values proposed making it difficult to recommend one value over 
another. However, given current workplace exposure reports and when using the highest OEL 
values, this should be an incentive to lower exposures in the workplace. 
Implications for research 
There is a need to develop a coordinated approach among researchers and relevant 
stakeholders towards the harmonization of OEL derivation for nanomaterials. This will 
improve transparency and communication towards stakeholders. Communication will also be 
improved with a common terminology used by all the parties involved from academia to 
professionals and workers. Moreover, the recent and emerging need for nanomaterial 
 
exposure limits provides a unique opportunity for organizations worldwide to finally find 
consensus about the naming of OELs. 
Currently, there is variation in the selection and analysis of animal studies used to underpin 
quantitative risk assessment. Using systematic reviews of animal studies, including 
systematic risk of bias assessment (Hooijmans and Ritskes-Hoitinga, 2013, Hooijmans et al., 
2014), would lead to more uniform conclusions. Finally, agreement about interspecies and 
intraspecies adjustment factors would be needed to come to more similar conclusions and 
exposure values. 
Regular updating of this list will be necessary to keep up with scientific progress in both the 
field of (nano) particle toxicological research and in the field of OEL derivation. 
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Study 
reference 
Professional 
Group/Institution 
Funded by Country Nanomaterial(s) 
AGS 2013 German 
Hazardous 
Substances 
Committee, 
German Federal 
Institute for 
Occupational 
Safety and Health 
(BAuA) 
National 
Institute 
Germany Granular biopersistent particles 
and non-entangled fibrous 
nanomaterials 
Aschberger 
2011 
ENRHES project 
2009 
European 
project 
EU Carbon nanotubes (multi-walled), 
fullerenes, nanosilver and nano 
titanium dioxide 
BSI 2007 British Standards 
Institution  
National 
Institute 
UK Fibrous nanomaterials, CMAR, 
insoluble and soluble 
nanomaterials 
Guidotti 
2010 
Archives of 
Environmental 
and Occupational 
Health, journal 
Independent Canada Environmental fine particulate 
matter ≤ 2500nm 
Kuempel 
2006 
National Institute 
for Occupational 
Safety and Health 
(NIOSH) 
National 
Institute 
USA Titanium dioxide (ultrafine) and 
carbon black 
Luizi 2009 Nanocyl Company Belgium Carbon nanotubes 
McGarry 
2013 
International 
Laboratory for Air 
Quality and 
Health, 
Queensland 
University of 
Technology 
University Australia Nanomaterials 
Nakanishi 
2015 
New Energy and 
Industrial 
Technology 
Development 
Organization 
(NEDO) 
National 
Institute 
Japan Carbon nanotube group: single-, 
double- and multi-walled 
nanotubes 
NIOSH 2011 National Institute 
for Occupational 
Safety and Health 
(NIOSH) 
National 
Institute 
USA Titanium dioxide (ultrafine) 
NIOSH 2013 National Institute 
for Occupational 
Safety and Health 
(NIOSH) 
National 
Institute 
USA Carbon nanotubes and carbon 
nanofibers 
Ogura 2011 New Energy and 
Industrial 
Technology 
Development 
National 
Institute 
Japan Titanium dioxide 
Organization 
(NEDO) 
Pauluhn 
2010 
Institute of 
Toxicology, Bayer 
Schering 
Pharmaceuticals 
Company Germany Carbon nanotubes (multi-walled) 
Pauluhn 
2011 
Institute of 
Toxicology, Bayer 
Schering 
Pharmaceutical 
Company Germany Inhaled poorly soluble particles 
Shinohara 
2011 
New Energy and 
Industrial 
Technology 
Development 
Organization 
(NEDO) 
National 
Institute 
Japan Carbon fullerenes (C60) 
Stockmann-
Juvala 2014 
Scaffold SPD-7 European 
project 
EU Silicon dioxide (amorphous silica), 
titanium dioxide, carbon 
nanofibers, nanocellulose, 
nanoclays and low-toxicity dusts 
Stone 2009 ENRHES project 
2009 
European 
project 
EU Carbon nanotubes, fullerenes, 
metals and metal oxides 
Swidwinska 
2014 
Nofer Institute of 
Occupational 
Medicine, Lodz 
National 
Institute 
Poland Titanium dioxide 
Swidwinska 
2015 
Nofer Institute of 
Occupational 
Medicine, Lodz 
National 
Institute 
Poland Nanosilver 
van 
Broekhuizen 
2012 
IVAM, University 
of Amsterdam 
University The 
Netherlands 
Metals and metal oxides, 
biopersistent granular 
nanomaterial 
Warheit 
2013 
DuPont Company USA Titanium dioxide (nanoscale) 
Table 1: Description of studies proposing OELs included in the review (N=20) 
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n µg/m
3 
Particle 
concentratio
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(particle/ml, 
fibers/cm
3
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Surface 
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(nm
2
/cm
3
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Approa
ch 
Inhalation: General Approach 
MN
M 
Guidot
ti 
2010 
Fine particulate 
matter ≤ 2500nm 
BOEL 30 Environ
mental 
MN
M 
McGar
ry 
2013 
Airborne particles 
from 
nanotechnology 
processes 
PCVs 3 times LBPC 
for over 30 
minutes 
Environ
mental 
Inhalation: Categorical Approach 
CMA
R 
BSI 
2007 
CMAR 
nanomaterials 
BEL 0.1 x bulk 
WEL 
Bridgin
g 
Fiber
s 
AGS 
2013 
Non-entangled 
fibrous NM 
Acceptance 
level (default), 
respirable 
fraction 
0.01 Bridgin
g/Grou
ping 
Fiber
s 
BSI 
2007 
Fibrous 
nanomaterials 
BEL 0.01 Bridgin
g/Grou
ping 
Fiber
s 
Stock
mann-
Juvala 
2014 
Carbon nanofibers, 
CNFs 
OEL 0.01 Bridgin
g/Grou
ping 
Fiber
s 
van 
Broek
huizen 
2012 
Carbon nanotubes, 
CNTs, insoluble 
NM with high 
aspect ratio ˃3:1  
NRV 0.01 Bridgin
g/Grou
ping 
GBP AGS 
2013 
in operations with 
NM: nanosized 
GBP with no 
specific toxicity 
OEL respirable 
fraction, 
default 
500 Groupi
ng 
GBP AGS 
2013 
no specific 
operations with 
NM: granular 
biopersistent 
particles 
OEL respirable 
fraction 
1250 Groupi
ng 
GBP BSI 
2007 
Insoluble 
nanomaterials 
BEL 0.066 x bulk 
WEL 
20000 Bridgin
g 
GBP Pauluh
n 2011 
Inhaled poorly 
soluble particles 
DNEL 0.5 µl 
PMrespirable
/m
3
 x 
agglomerate 
density 
Catego
rical 
QRA/G
rouping 
GBP van 
Broek
huizen 
2012 
Metals and metal 
oxides, 
biopersistent 
granular NM ˃6000 
kg/m
3
NRV 20000 Groupi
ng 
GBP van 
Broek
huizen 
2012 
Metals and metal 
oxides, 
biopersistent 
granular NM ˂6000 
NRV 40000 Groupi
ng 
kg/m
3
Low-
toxici
ty 
dust 
Stock
mann-
Juvala 
2014 
OEL 300 (respirable fraction), 
4000 (inhalable fraction) 
Bridgin
g/Grou
ping 
Non 
bio-
persi
stent 
van 
Broek
huizen 
2012 
Non-biopersistent 
granular NM 1-100 
nm 
NRV applicable 
OEL, WEL 
Bridgin
g 
Solu
ble 
BSI 
2007 
Soluble 
nanomaterials 
BEL 0.5 x bulk 
WEL 
Bridgin
g 
Inhalation: Specific Approach 
Carb
on 
Aschb
erger 
2011 
Multi-walled 
carbon nanotubes, 
MWCNT 10 nm 
INEL 1 QRA 
Carb
on 
Aschb
erger 
2011 
Multi-walled 
carbon nanotubes, 
MWCNT 140 nm 
INEL 2 QRA 
Carb
on 
Luizi 
2009 
Carbon nanotubes, 
CNTs 
No effect 
concentration 
in air 
2.5 QRA 
Carb
on 
Nakani
shi 
2015 
Carbon nanotube 
group, SWCNT, 
DWCNT, MWCNT 
OEL 15 years 30 QRA 
Carb
on 
NIOSH 
2013 
All carbon 
nanotubes and 
nanofibers 
REL respirable 
elemental 
carbon 
˂ 1 QRA 
Carb
on 
Pauluh
n 2010 
Multi-walled 
carbon nanotubes, 
MWCNT Baytubes 
® 
OEL, inhalable 
fraction 
50 QRA 
Carb
on 
Stone 
2009 
MWCNT DNEL chronic 
inhalation, 
systemic 
immune effect 
0.67 QRA 
Carb
on 
Kuem
pel 
2006 
Carbon black, CB 
ultrafine 
BMDL 45 years 
(lung 
dosimetry, 
model 1) 
120 QRA 
Carb
on 
Kuem
pel 
2006 
Carbon black, CB 
ultrafine 
BMDL 45 years 
(lung 
dosimetry, 
model 2) 
240 QRA 
Carb
on 
Aschb
erger 
2011 
Fullerenes, C60 INEL 7.4 QRA 
Carb
on 
Shinoh
ara 
2011 
Fullerenes, C60 OEL (PL) 15 
years 
390 QRA 
Nano
cellul
ose 
Stock
mann-
Juvala 
2014 
Nanocellulose OEL 0.01 Bridgin
g 
Nano
clays 
Stock
mann-
Nanoclays OEL 300 (respirable fraction), 
4000 (inhalable fraction) 
Bridgin
g/Grou
Juvala 
2014 
ping 
Nano
silver 
Aschb
erger 
2011 
Nano Ag INEL lung 
function 
0.33 QRA 
Nano
silver 
Aschb
erger 
2011 
Nano Ag INEL lung 
other effects 
0.67 QRA 
Nano
silver 
Stone 
2009 
Nano Ag DNEL lung 
exposure, 
extrapolating 
factor 10 
0.098 1200 2.2 x 10
6
QRA 
Nano
silver 
Stone 
2009 
Nano Ag DNEL lung 
exposure, 
extrapolating 
factor 3 
0.33 4000 7.2 x 10
6
QRA 
Nano
silver 
Stone 
2009 
Nano Ag DNEL liver 
effect 
0.67 7000 1.2 x 10
7
QRA 
Nano
silver 
Swidw
inska 
2015 
Nano Ag MAC-TWA 
inhalable 
fraction 
10 QRA 
Silico
n 
dioxi
de 
Stock
mann-
Juvala 
2014 
Amorphous silica, 
SiO2
OEL respirable 
fraction 
300 QRA 
Titan
ium 
dioxi
de 
Aschb
erger 
2011 
TiO2 INEL 17 QRA 
Titan
ium 
dioxi
de 
Kuem
pel 
2006 
TiO2 ultrafine BMDL 45 years 
(lung 
dosimetry, 
model 1) 
73 QRA 
Titan
ium 
dioxi
de 
Kuem
pel 
2006 
TiO2 ultrafine BMDL 45 years 
(lung 
dosimetry, 
model 2) 
140 QRA 
Titan
ium 
dioxi
de 
NIOSH 
2011 
TiO2 ultrafine REL (up to 10 
h/day, 40 
h/week) 
300 QRA 
Titan
ium 
dioxi
de 
Ogura 
2011 
TiO2 OEL (PL) 15 
years 
610 QRA 
Titan
ium 
dioxi
de 
Stock
mann-
Juvala 
2014 
TiO2 OEL respirable 
fraction 
100 QRA 
Titan
ium 
dioxi
de 
Swidw
inska 
2014 
TiO2 MAC 300 QRA 
Titan
ium 
dioxi
Warhe
it 
2013 
High surface 
reactivity anastase-
rutile nanoscale 
OEL 1000 QRA 
de TiO22
Titan
ium 
dioxi
de 
Warhe
it 
2013 
Low surface 
reactivity 
nanoscale TiO2
OEL 2000 QRA 
Dermal 
Carb
on 
Stone 
2009 
MWCNT DNEL dermal 
chronic 
exposure, 
assessment 
factor 3 
0.414 
mg/person 
bodyweight 
QRA 
Carb
on 
Stone 
2009 
MWCNT DNEL dermal 
chronic 
exposure 
1.241 
mg/person 
bodyweight 
QRA 
Oral 
Carb
on 
Stone 
2009 
Fullerite, mixture 
of C60 + C70
DNEL oral 
acute 
exposure 
40 mg/kg 
body weight 
QRA 
Carb
on 
Stone 
2009 
Water soluble C60, 
polyalkylsulfonated 
DNEL oral 
chronic 
exposure 
0.17 mg/kg 
body weight 
QRA 
Acute 
MN
M 
McGar
ry 
2013 
Airborne particles 
from 
nanotechnology 
processes 
PCVs, single 
short-term 
measurement 
5 times the 
local particle 
reference 
value 
Environ
mental 
Carb
on 
Stone 
2009 
MWCNT DNEL acute 
inhalation, 
systemic 
immune effect 
4.02 QRA 
Carb
on 
Aschb
erger 
2010 
Fullerenes, C60 INEL short 
term, inhalable 
fraction 
44.4 QRA 
Carb
on 
Stone 
2009 
MWCNT DNEL acute 
inhalation, 
pulmonary 
effect 
201 QRA 
Carb
on 
Stone 
2009 
MWCNT DNEL dermal 
acute 
exposure 
7448 
µg/person 
bodyweight 
QRA 
Carb
on 
Stone 
2009 
MWCNT DNEL dermal 
acute 
exposure, 
assessment 
factor 3 
2483 
µg/person 
bodyweight 
QRA 
Table 2: Proposed Occupational Exposure Limits for Manufactured Nanomaterials 
AGS = German Hazardous Substances Committee 
BEL = benchmark exposure level 
BMDL = benchmark dose lower (95% confidence limit of the benchmark dose, BMD) 
BOEL = benchmark occupational exposure level 
BSI = British Standards Institution  
CMAR = carcinogenic, mutagenic, asthmagenic or a reproductive toxin 
CNT = carbon nanotube 
DNEL = derived no-effect level 
DWCNT = double-walled carbon nanotube 
GBP = granular biopersistent particles 
INEL = indicative no effect level 
LBPC = local background particle concentration 
MAC = maximum admissible concentration 
MAC-TWA = maximum admissible concentration time weighted average 
MNM = manufactured nanomaterial 
MWCNT = multi-walled carbon nanotube 
NIOSH = National Institute for Occupational Safety and Health (United States) 
NM = nanomaterial 
NRV = nano reference value 
OEL = occupational exposure limit 
OEL (PL) = occupational exposure limit period-limited 
PCVs = particle control values  
REL = recommended exposure limit 
QRA = traditional quantitative risk assessment  
SWCNT = single-walled carbon nanotube 
TWA = time weighted average exposure over the 8-hour working day 
WEL = workplace exposure limit 

